CAS 99697-24-2
:Acide (3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-diméthylhexadécahydro-1H-cyclopenta[a]phénanthrène-17-yl]butanoïque
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
24-Norursodeoxycholic acid
CAS :24-Norursodeoxycholic acid (nor-UDCA) is a Ursodeoxycholic Acid derivative. It has potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.Formule :C23H38O4Degré de pureté :99.69%Couleur et forme :White SolidMasse moléculaire :378.545424-Norursodeoxycholic acid
CAS :24-Norursodeoxycholic acidFormule :C23H38O4Degré de pureté :99.5%Masse moléculaire :378.55(3α,5β,7β)-3,7-Dihydroxy-24-norcholan-23-oic acid
CAS :Formule :C23H38O4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :378.545424-Nor Ursodeoxycholic Acid
CAS :Produit contrôléApplications Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formule :C23H38O4Couleur et forme :NeatMasse moléculaire :378.5524-Nor Ursodeoxycholic Acid-d5
CAS :Produit contrôléApplications Labelled Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formule :C23D5H33O4Couleur et forme :NeatMasse moléculaire :383.576(R)-3-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoic acid
CAS :Formule :C23H38O4Degré de pureté :97%Masse moléculaire :378.5524-Norursodeoxycholic acid
CAS :Produit contrôlé24-Norursodeoxycholic acid is a synthetic bile acid derivative, which is a modified form derived from natural bile acids. Its primary source is the chemical synthesis of ursodeoxycholic acid analogs. The mode of action involves modulating bile acid composition within the liver, thereby reducing cytotoxicity associated with bile acid accumulation. This modulation helps protect hepatocytes from damage, reducing liver inflammation and fibrosis.
Formule :C23H38O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :378.55 g/mol







